Related references
Note: Only part of the references are listed.Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
Erin A. Bohula et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients
Anselm K. Gitt et al.
ATHEROSCLEROSIS (2016)
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano et al.
EUROPEAN HEART JOURNAL (2016)
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
Emanuele Di Angelantonio et al.
LANCET (2016)
Body mass index correlates with atherogenic Lipoprotein profile even in nonobese, normoglycemic, and normolipidemic healthy men
Montse Guardiola et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2015)
Variations in statin prescribing for primary cardiovascular disease prevention: cross-sectional analysis
Robert Fleetcroft et al.
BMC HEALTH SERVICES RESEARCH (2014)
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Neil J. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants
Yuan Lu et al.
LANCET (2014)
Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women
F. Magkos et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Mechanisms linking obesity with cardiovascular disease
Luc F. Van Gaal et al.
NATURE (2006)
Share Paper
